Premium
Pten controls B‐cell responsiveness and germinal center reaction by regulating the expression of IgD BCR
Author(s) -
Setz Corinna S,
Khadour Ahmad,
Renna Valerio,
Iype Joseena,
Gentner Eva,
He Xiaocui,
Datta Moumita,
Young Marc,
Nitschke Lars,
Wienands Jürgen,
Maity Palash C,
Reth Michael,
Jumaa Hassan
Publication year - 2019
Publication title -
the embo journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.484
H-Index - 392
eISSN - 1460-2075
pISSN - 0261-4189
DOI - 10.15252/embj.2018100249
Subject(s) - germinal center , library science , biology , immunology , b cell , computer science , antibody
In contrast to other B‐cell antigen receptor ( BCR ) classes, the function of IgD BCR on mature B cells remains largely elusive as mature B cells co‐express IgM, which is sufficient for development, survival, and activation of B cells. Here, we show that IgD expression is regulated by the forkhead box transcription factor FoxO1, thereby shifting the responsiveness of mature B cells towards recognition of multivalent antigen. FoxO1 is repressed by phosphoinositide 3‐kinase ( PI 3K) signaling and requires the lipid phosphatase Pten for its activation. Consequently, Pten‐deficient B cells expressing knock‐ins for BCR heavy and light chain genes are unable to upregulate IgD. Furthermore, in the presence of autoantigen, Pten‐deficient B cells cannot eliminate the autoreactive BCR specificity by secondary light chain gene recombination. Instead, Pten‐deficient B cells downregulate BCR expression and become unresponsive to further BCR ‐mediated stimulation. Notably, we observed a delayed germinal center ( GC ) reaction by IgD‐deficient B cells after immunization with trinitrophenyl‐ovalbumin ( TNP ‐Ova), a commonly used antigen for T‐cell‐dependent antibody responses. Together, our data suggest that the activation of IgD expression by Pten/FoxO1 results in mature B cells that are selectively responsive to multivalent antigen and are capable of initiating rapid GC reactions and T‐cell‐dependent antibody responses.